ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,300Medicare Part D Prescriptions Filled, Including Refills

Rank: 187 out of 1206

$550K Total Retail Price of All Prescriptions

Rank: 123 out of 1206

533 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,858 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LISINOPRIL 400 311 1 4
SIMVASTATIN 381 294 2 1
HYDROCODONE-ACETAMINOPHEN 376 208 S3 3 7
LEVOTHYROXINE SODIUM 337 256 4 2
AMLODIPINE BESYLATE 303 256 5 6
OMEPRAZOLE 253 129 6 3
METFORMIN HCL 232 164 7 10
FUROSEMIDE 230 195 8 5
METOPROLOL TARTRATE 223 186 9 9
POTASSIUM CHLORIDE 203 156 10 12
HYDROCHLOROTHIAZIDE 180 126 11 11
TRAMADOL HCL 175 126 12 17
WARFARIN SODIUM 170 136 13 8
METOPROLOL SUCCINATE 155 119 14 15
CITALOPRAM HBR 138 113 15 16
GABAPENTIN 127 46 16 18
ROPINIROLE HCL 110 79 17 77
CRESTOR 110 95 17 30
ATORVASTATIN CALCIUM 96 94 19 13
ATENOLOL 95 70 20 14
VENLAFAXINE HCL ER 94 33 21 89
TRAZODONE HCL 90 53 22 37
PRAVASTATIN SODIUM 86 71 23 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 59 24 27
NEXIUM 82 57 25 47
MELOXICAM 82 56 25 35
ALLOPURINOL 79 57 27 24
PANTOPRAZOLE SODIUM 78 51 28 54
CYCLOBENZAPRINE HCL 76 25 R 29 80
ZOLPIDEM TARTRATE 75 40 30 25
CARVEDILOL 68 54 31 32
NAPROXEN 67 21 32 105
PREDNISONE 66 59 33 28
RISPERIDONE 66 16 33 74
RANITIDINE HCL 65 30 35 23
OXYCONTIN 64 18 S2 36 165
CLONIDINE HCL 64 57 36 88
SYNTHROID 62 38 38 94
DICYCLOMINE HCL 60 24 39 279
FLUTICASONE PROPIONATE 60 52 39 42
TORSEMIDE 60 47 39 144
SUCRALFATE 59 45 42 143
GLIPIZIDE 58 28 43 64
DOXYCYCLINE HYCLATE 58 27 43 103
OXYCODONE-ACETAMINOPHEN 57 0 S2 45 106
LOSARTAN POTASSIUM 56 55 46 20
NAMENDA 56 54 46 36
OXYCODONE HCL 55 0 S2 48 107
DONEPEZIL HCL 55 52 48 29
FLUOXETINE HCL 55 43 48 52
LANTUS 55 31 48 38
SPIRONOLACTONE 54 20 52 41
ADVAIR DISKUS 51 31 53 55
VERAPAMIL ER 50 46 54 97
TAMSULOSIN HCL 50 33 54 26
DIOVAN 50 25 54 57
CYMBALTA 50 31 54 63
SERTRALINE HCL 50 37 54 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.